PsiThera is a biotechnology company focused on developing oral medicines for validated immunology targets, including the TNF superfamily and beyond. The company uses its QUAISAR platform to model biologically relevant protein motion and identify cryptic pockets that enable oral small-molecule therapies as alternatives to biologics. It combines computational intelligence with integrated structural biophysics and in-house software to guide drug discovery, supported by the PsiVision data platform for rapid decision-making. Based in the biotechnology sector, PsiThera aims to bring oral therapies.
No recent news for this company.